An insider’s view into the preclinical development of an approved exon skipping drug
Time: 11am – 12pm EST
Date: November 3, 2022
Dr. Arechavala works on developing new drugs for neuromuscular disorders. As there are not many for these rare diseases, neuromuscular disorders have been at the forefront of the clinical development of RNA based therapies. She is specialised in quantifying the effects of these drugs, developing methods to assess their efficacy both pre- and clinically. During the webinar she will cover all the things we did not know when we started developing eteplirsen.
Ikerbasque Research Professor, PhD
Biocruces Bizkaia Health Research Institute